博迅生物
(836504)
| 流通市值：3.70亿 | | | 总市值：9.78亿 |
| 流通股本：1636.77万 | | | 总股本：4333.31万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 18,480,719.95 | 44,750,712.18 | 40,513,208.51 | 107,991,468.99 |
| 应收票据及应收账款 | 27,926,909.03 | 30,344,889.2 | 23,528,922.47 | 15,461,132.59 |
| 其中：应收票据 | 5,782,903.15 | 3,644,086.88 | 6,002,486.57 | 12,015,393.29 |
| 应收账款 | 22,144,005.88 | 26,700,802.32 | 17,526,435.9 | 3,445,739.3 |
| 应收款项融资 | 1,163,932.86 | 803,417.42 | 648,971.01 | 3,746,385.83 |
| 预付款项 | 1,997,955.96 | 2,083,859.18 | 2,181,055.29 | 1,869,666.7 |
| 其他应收款合计 | 240,215.74 | 179,395.96 | 232,829.97 | 138,167.17 |
| 其中:应收利息 | 34,939.74 | 5,449.32 | - | - |
| 存货 | 28,918,802.91 | 30,614,379.35 | 34,313,741.6 | 31,373,374.5 |
| 一年内到期的非流动资产 | 21,984,835.35 | 1,200,335.35 | 1,200,335.35 | 1,200,335.35 |
| 其他流动资产 | 2,924,261 | 2,677,524.21 | 2,211,031.87 | 31,145,077.25 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 184,696,788.75 | 154,093,942.57 | 184,970,178.15 | 192,925,608.38 |
| 非流动资产: | | | | |
| 长期应收款 | 16,559,909.72 | 16,409,947.45 | 16,272,497.02 | 16,116,597.93 |
| 固定资产 | 17,890,325.75 | 18,272,878.74 | 19,020,593.23 | 19,514,000.24 |
| 在建工程 | 19,334,478.29 | 18,625,338.6 | 571,649.1 | 162,567.55 |
| 使用权资产 | 5,173,672.36 | 5,405,545.18 | 5,637,418 | 3,637,418.69 |
| 无形资产 | 9,410,167.13 | 9,511,820.81 | 9,647,598.48 | 9,733,336.19 |
| 长期待摊费用 | 489,042.87 | 575,977.83 | 662,912.79 | 749,847.75 |
| 递延所得税资产 | 4,154,243.45 | 3,909,977.56 | 4,097,843.68 | 3,962,435.37 |
| 其他非流动资产 | - | 20,646,500 | 20,510,000 | 20,373,500 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 73,011,839.57 | 93,357,986.17 | 76,420,512.3 | 74,249,703.72 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 257,708,628.32 | 247,451,928.74 | 261,390,690.45 | 267,175,312.1 |
| 流动负债: | | | | |
| 短期借款 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 应付票据及应付账款 | 15,543,625.02 | 14,924,969.34 | 18,469,640.74 | 19,561,084.6 |
| 应付账款 | 15,543,625.02 | 14,924,969.34 | 18,469,640.74 | 19,561,084.6 |
| 合同负债 | 3,259,362.8 | 951,914.37 | 1,156,889.2 | 1,018,634.07 |
| 应付职工薪酬 | 2,152,741.81 | 2,197,618.34 | 2,277,227.86 | 3,965,717.51 |
| 应交税费 | 2,428,505.47 | 3,487,571.51 | 3,364,685.86 | 5,455,567.7 |
| 其他应付款合计 | 3,885,904.11 | 2,320,885.17 | 3,379,491.88 | 6,576,944.16 |
| 一年内到期的非流动负债 | 2,003,228.67 | 2,003,228.67 | 2,003,228.67 | 1,200,335.35 |
| 其他流动负债 | 4,974,228.58 | 2,477,955.4 | 5,374,565.26 | 7,534,179.07 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 44,247,596.46 | 38,364,142.8 | 46,025,729.47 | 55,312,462.46 |
| 非流动负债: | | | | |
| 租赁负债 | 19,373,901.09 | 19,207,657 | 19,452,235.59 | 17,385,940.86 |
| 递延收益 | 1,273,750 | 1,328,500 | 1,383,250 | 1,438,000 |
| 递延所得税负债 | 289,714.83 | 319,030.29 | 352,385.03 | 24,516.29 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 20,937,365.92 | 20,855,187.29 | 21,187,870.62 | 18,848,457.15 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 65,184,962.38 | 59,219,330.09 | 67,213,600.09 | 74,160,919.61 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 43,333,100 | 43,333,100 | 43,333,100 | 43,333,100 |
| 资本公积 | 114,590,131.66 | 114,590,131.66 | 114,590,131.66 | 114,590,131.66 |
| 盈余公积 | 16,737,149.39 | 16,737,149.39 | 16,737,149.39 | 16,737,149.39 |
| 未分配利润 | 17,863,284.89 | 13,572,217.6 | 19,516,709.31 | 18,354,011.44 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 192,523,665.94 | 188,232,598.65 | 194,177,090.36 | 193,014,392.49 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 192,523,665.94 | 188,232,598.65 | 194,177,090.36 | 193,014,392.49 |
| 负债和股东权益合计 | 257,708,628.32 | 247,451,928.74 | 261,390,690.45 | 267,175,312.1 |
| 公告日期 | 2024-10-30 | 2024-08-21 | 2024-04-26 | 2024-03-15 |
| 审计意见(境内) | | | | 标准无保留意见 |